Use of beta-blocking agents with group therapy in a smoking withdrawal clinic
- PMID: 6384510
- PMCID: PMC1440107
- DOI: 10.1177/014107688407700807
Use of beta-blocking agents with group therapy in a smoking withdrawal clinic
Abstract
A controlled trial was carried out into the relative efficacy of two beta-blocking agents (oxprenolol and metoprolol) as adjuncts to group therapy in a smoking withdrawal clinic. There was no evidence to indicate that these were of specific value in assisting smoking withdrawal.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources